Search Results - Laack, Eckart

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program by Frost, Nikolaj (Author) , Christopoulos, Petros (Author) , Kauffmann-Guerrero, Diego (Author) , Stratmann, Jan (Author) , Riedel, Richard (Author) , Schaefer, Monica (Author) , Alt, Jürgen (Author) , Gütz, Sylvia (Author) , Christoph, Daniel C. (Author) , Laack, Eckart (Author) , Faehling, Martin (Author) , Fischer, Richard (Author) , Fenchel, Klaus (Author) , Haen, Sebastian P. (Author) , Heukamp, Lukas (Author) , Schulz, Christian (Author) , Griesinger, Frank (Author) ,

• Verlag, lizenzpflichtig, Volltext

Efficacy of docetaxel plus ramucirumab as palliative third-line therapy following second-line immune-checkpoint-inhibitor treatment in patients with non-small-cell lung cancer stag... by Brückl, Wolfgang M. (Author) , Reck, Martin (Author) , Rittmeyer, Achim (Author) , Kollmeier, Jens (Author) , Wesseler, Claas (Author) , Wiest, Gunther H. (Author) , Christopoulos, Petros (Author) , Tufman, Amanda (Author) , Hoffknecht, Petra (Author) , Ulm, Bernhard (Author) , Reich, Fabian (Author) , Ficker, Joachim H. (Author) , Laack, Eckart (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer by Stratmann, Jan Alexander (Author) , Michels, Sebastian (Author) , Hornetz, Sofia Emily Tsion (Author) , Christoph, Daniel C. (Author) , Sackmann, Sandra (Author) , Spengle, Werner (Author) , Bischoff, Helge (Author) , Biscaldi-Schäfer, Verona Monica (Author) , Alt, Jürgen (Author) , Müller, Annette (Author) , Laack, Eckart (Author) , Kimmich, Martin (Author) , Griesinger, Frank (Author) , Sebastian, Martin (Author) ,

• Resolving-System, Volltext